An intrinsic value analysis of Texas Instruments (TXN) suggests the stock is currently overvalued by approximately 26% relative to its fair price. Using a 2-stage Free Cash Flow to Equity (FCFE) model, the stock's fair value is estimated at $175, significantly lower than its current market price of $221. While market analysts maintain a price target of $219, this remains well above the valuation derived from projected future cash flows. The company's high P/E ratio further underscores the premium at which it is trading, potentially signaling a correction risk. Despite these valuation concerns, Texas Instruments continues to demonstrate robust earnings growth and strong debt coverage capabilities. This discrepancy between market price and intrinsic value may prompt value-oriented investors to exercise caution in the near term.
Get AI-powered deep analysis for every story with a paid subscription
Upgrade for Analysis